Clelia Madeddu

University of Cagliari

Italy

Research Interests

Explore related searches

Professors in Italy Professors in Immunology Immunology professors in Italy

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

Articles (10)

Researchers have long attempted to stimulate the immune system of cancer patients as a therapeutic strategy [...]

Year:

2023

Year:

2023

Year:

2022

Year:

2022

Year:

2022

Year:

2021

Year:

2021

Year:

2020

Year:

2020

Year:

2020

Collaborators (6)

Silvia Busquets

University of Barcelona

SPAIN

View details

Mario Scartozzi

ITALY

View details

Sofia Cosentino

University of Cagliari

ITALY

View details

Roberta Agabio

University of Cagliari

ITALY

View details

Antonio Macciò

Full Professor

University of Cagliari

ITALY

View details

Monica Deiana

University of Cagliari

ITALY

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Clelia Madeddu

Research Interests

Explore related searches

Contact this professor

Articles (10)

Molecular Basis and Advances in Targeted Immunotherapy for Cancer

Effect of Cancer-Related Cachexia and Associated Changes in Nutritional Status, Inflammatory Status, and Muscle Mass on Immunotherapy Efficacy and Survival in Patients with Advanced Non-Small Cell Lung Cancer

Pathogenic and Prognostic Roles of Paraneoplastic Leukocytosis in Cervical Cancer: Can Genomic-Based Targeted Therapies Have a Role? A Literature Review and an Emblematic Case Report

Alcohol Consumption Is a Modifiable Risk Factor for Breast Cancer: Are Women Aware of This Relationship?

EGFR-Mutated Non-Small Cell Lung Cancer and Resistance to Immunotherapy: Role of the Tumor Microenvironment

COVID-19 and cytokine storm syndrome: can what we know about interleukin-6 in ovarian cancer be applied?

Next-Generation Sequencing Whole-Genome Analysis for Targeted Treatment Approach of Metastatic Bartholin Gland Adenocarcinoma: An Emblematic Case Report and Review of the Literature

Defibrotide in the COVID-19 coagulopathy: What is the timing?

Introducing immunotherapy for advanced hepatocellular carcinoma patients: Too early or too fast?

Multifactorial pathogenesis of COVID-19-related coagulopathy: Can defibrotide have a role in the early phases of coagulation disorders?

Collaborators (6)

Silvia Busquets

Mario Scartozzi

Sofia Cosentino

Roberta Agabio

Antonio Macciò

Monica Deiana

Make your next move.